TWYNSTA
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of TWYNSTA in Canada?
Yes. TWYNSTA 40MG 5MG has an active shortage reported to Health Canada (last updated November 2, 2026).
Why is TWYNSTA not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will TWYNSTA be available again?
The manufacturer's estimated resolution date is February 1, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02371022
Strength
40MG 5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
TELMISARTAN AMLODIPINE
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02242119
250MG · DIN 02273322
20MCG · DIN 02247686
DIN 02419106
DIN 02231675
0.4MG · DIN 02270102
20MG · DIN 02415666
40MG · DIN 02415682
30MG · DIN 02415674
DIN 02459752
DIN 02459760
DIN 02441888